Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Sloan Sheldon. Insider active across 1 company, notably Spyre Therapeutics, Inc.. Cumulatively, 10 reports have been recorded. Split: 0 buy · 8 sells. Total volume traded: €5.1m. Activity tracked since 1 April 2026. The latest transaction was filed on 1 May 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Sloan Sheldon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
78,333 shares@ US$27.460.027% mcap27.7% of flowCommon StockSEC:0002038798-26-000004:0
21,306 shares@ US$69.530.019% mcap19.1% of flowCommon StockSEC:0002038798-26-000004:1
19,656 shares@ US$70.610.018% mcap17.9% of flowCommon StockSEC:0002038798-26-000004:2
8,777 shares@ US$71.560.0080% mcap8.1% of flowCommon StockSEC:0002038798-26-000004:3
12,777 shares@ US$72.940.012% mcap12.0% of flowCommon StockSEC:0002038798-26-000004:4
10,358 shares@ US$73.740.0097% mcap9.9% of flowCommon StockSEC:0002038798-26-000004:5
5,059 shares@ US$74.600.0048% mcap4.9% of flowCommon StockSEC:0002038798-26-000004:6
400 shares@ US$75.370.0004% mcap0.4% of flowCommon StockSEC:0002038798-26-000004:7
7,958 shares@ US$21.662.1% of flowCommon StockSEC:0001636282-26-000030:0
7,958 shares@ US$50.004.8% of flowCommon StockSEC:0001636282-26-000030:1
About Sloan Sheldon
Sloan Sheldon is a declarant linked to Spyre Therapeutics, Inc., where the listed role is Chief Medical Officer. The record shows 10 filings in total, and across the 10 sampled filings from 2026-04-03 to 2026-05-01, the transactions are all sales, for total sell volume of EUR 5118342.